University of North Carolina Neurosciences Hospital
Chapel Hill, North Carolina, United States
Neurological ward in Chapel Hill, North Carolina
101 Manning Dr, Chapel Hill, NC 27514
About University of North Carolina Neurosciences Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Seaside Therapeutics, Inc.
7
Clinical Trials at University of North Carolina Neurosciences Hospital
During the past decade, University of North Carolina Neurosciences Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome
2008-11-01
2010-05-01
Completed
63
Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001
2009-01-01
Completed
Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders
2009-02-01
2010-09-01
Completed
32
Biomarker and DNA Collection in Subjects Participating in Protocol 22003
2009-05-01
Completed
32
An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome
2009-11-01
2012-12-01
Terminated
45
An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders
2010-02-01
2012-12-01
Terminated
32
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
2011-05-01
2012-09-01
Completed
150
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of North Carolina Neurosciences Hospital
According to Clinical.Site data, the most researched conditions in "University of North Carolina Neurosciences Hospital" are
"Fragile X Syndrome" (4 trials) and "Autism Spectrum Disorders" (3 trials). Many other conditions were trialed in "University of North Carolina Neurosciences Hospital" in a lesser frequency.
Clinical Trials Intervention Types at University of North Carolina Neurosciences Hospital
Most popular intervention types in "University of North Carolina Neurosciences Hospital" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Arbaclofen" (3 trials), "STX209" (3 trials), "Placebo" (1 trials) and "arbaclofen" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of North Carolina Neurosciences Hospital
The vast majority of trials in "University of North Carolina Neurosciences Hospital" are
7 trials for "All" genders.
Clinical Trials Status at University of North Carolina Neurosciences Hospital
Currently, there are NaN active trials in "University of North Carolina Neurosciences Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in University of North Carolina Neurosciences Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in University of North Carolina Neurosciences Hospital, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".